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Table. High-sensitivity C-reactive protein (hsCRP), B-type natriuretic
peptide (BNP), and other predictors of major adverse limb events
(MALE) and major adverse cardiovascular events (MACE)
HR (95% CI) P value
MALE at 2 years
Overall cohort
hsCRP 1.1 (1.0-1.2) .059
Male gender 1.6 (1.0-2.6) .062
Chronic limb ischemia 1.8 (1.1-3.1) .020
Outﬂow procedure 1.8 (1.1-3.2) .033
Procedure speciﬁc model
Endovascular
hsCRP 1.2 (1.0-1.4) .016
Outﬂow procedure 2.7 (1.4-5.2) .004
Obesity (BMI >30) 2.5 (1.3-4.8) .006
Open surgical
Male gender 3.4 (1.5 -7.8) .003
Hyperlipidemia 2.4 (1.2-5.1) .016
Vein bypass conduit (vs prosthetic) 3.5 (1.6-7.6) .002
MACE at 2 years
Overall cohort
BNP 1.02 (1.0-1.04) .018
Coronary artery disease 2.2 (0.9-5.4) .075
Procedure speciﬁc model
Endovascular
Age 1.05 (1.00-1.09) .033
Heart failure 10.6 (2.0-56.9) .006
Open surgical
BNP 1.03 (1.01-1.04) .003
BMI, Body mass index; CI, conﬁdence interval; HR, hazard ratio; MI,
myocardial infarction.
We used Cox proportional-hazards models to assess univariate and multivar-
iable covariates. HRs and 95% CI were calculated for each factor by univariate
analysis. All prognostic factors with P < .10 were included into a Cox multi-
variate analysis with back-wards entry to determine independent predictors.
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vs acute (0-30 days preoperatively) vs chronic (>30 days preoperatively) was
evaluated, and a Bonferroni correction with a P < .002 was used to declare
any result signiﬁcant at a 5% error rate. Logistic regression generalized esti-
mating equations and linear mixed models were used with MACE as the
outcome, and AHR/HRC, BB status, and the interaction between
AHR/HRC and BB status as ﬁxed factors.
Results: A total of 13,141 elective patients were reviewed (IIB: n¼ 8155
[62%];SIB:n¼2629[18%];oAAA:n¼2629[20%]).The rawnonrisk adjusted
rates of MACE and 30-day mortality were IIB: MACE, 9.8% (n ¼ 633) and
2.0% (n ¼ 126); SIB, 15.7% (n ¼ 263) and 2.6% (n ¼ 43); and oAAA, 21.7%
(n ¼ 486) and 3.3% (n ¼ 73). Rates of any preoperative BB exposure were
IIB, 66.5% (n ¼ 5412); SIB, 57% (n ¼ 1342); and oAAA, 74.2% (n ¼ 1949).
Association of AHR and HRC with outcomes was variable across patients and
procedures. AHR of <75 beats/min was associated with increased risk of
POMI for IIB patients across all cardiac risk strata (odds ratio [OR], 1.4; 95%
conﬁdence interval [CI], 1.03-1.9; P ¼ .03), whereas AHR >75 beats/min
was associated with increased risk for dysrhythmia (OR, 2.4; 95% CI, 1.6-3.6;
P ¼ .0001) and 30-day death (OR, 2.0; 95% CI, 1.3-3; P ¼ .001) in moder-
ate-risk and high-cardiac-risk patients. TheseHReffects disappearedwhen con-
trolling for BB status. SIB had no association between AHR and 30-day
mortality; however, AHR >75 beats/min was associated with an increased
risk of congestive heart failure congestive heart failure across all cardiac risk strata
(OR, 2.2; 95%CI, 1.2-3.8;P¼ .007). These effects also disappearedwhen con-
trolling for BB exposure. No association with HR and MACE outcome was
noted amongoAAApatients irrespectiveofBB status.However, 30-daymortal-
ity was increased (OR, 1.9; 95% CI, 1.03-3.4; P ¼ .04) for patients with AHR
>75 beats/min. This association was sustained when controlling for acute but
not chronic BB status. HRC was analyzed among all three operations, and
inconsistent associations with MACE or 30-day mortality were detected.
Conclusions: HRishighly confoundedbypatientpresentation,operative
variables, andBBtherapy.Thediscordancebetweencardiac risk andHRaswell as
the lack of consistent correlation to outcome makes this an unreliable predictor.
TheVQIhas elected to discontinue collectingheart rate data nationally given the
lack of sufﬁcient data to suggest its importance as an outcome measure.
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Introduction: Previously, our group reported on the preoperative
markers, high-sensitivity C-reactive protein (hsCRP), and B-type natriuretic
peptide (BNP) and their ability to predict future major adverse limb events
(MALE) and major adverse cardiovascular events (MACE) after lower ex-
tremity endovascular interventions. Others have reported the predictive po-
wer of these biomarkers for adverse outcomes in endovascular cohorts or
open surgical reconstructions. No literature currently addresses the use of
these biomarkers while comparing revascularization strategies or while
examining autologous and prosthetic reconstructions in surgical bypasses.
Methods: We retrospectively examined patients who underwent elec-
tive endovascular intervention or open surgical reconstruction for lower ex-
tremity peripheral arterial occlusive disease between January 1, 2007, and
December 31, 2013. All procedures were performed by a single operator. Pa-
tients’ preprocedural levels of hsCRP and BNP were measured, and they un-
derwent postprocedural ankle-brachial index measurement and duplex
ultrasound imaging or contrast angiography. Examined outcomes included
MALE (composite end point of target vessel revascularization, limb amputa-
tion, or disease progression) and MACE (stroke, myocardial infarction, or
death) occurring by 24 months. The relationship between baseline hsCRP
and BNP levels and time to the MALE and MACE was examined by univar-
iate and multivariate Cox proportional hazard regression analyses.
Results: The analysis included 245 limbs in 200 patients (median age
[interquartile range], 63 [53-71] years), with 156 limbs receiving endovas-
cular revascularization and 89 limbs receiving surgical reconstruction. The
surgical cohort was composed of a greater proportion of: men (62% vs
42%; P ¼ .01), limbs with critical limb ischemia (60% vs 17%; P < .01),
and outﬂow procedures (82% vs 39%; P < .01) compared with the endovas-
cular cohort. Preprocedural levels of hsCRP and BNP did not differ be-
tween surgically and endovascularly treated limbs (hsCRP, 0.57 [0.26-
1.18] vs 0.43 [0.22-0.96] mg/dL; P ¼ .21; BNP, 43 [18-112] vs 44
[18-82] pg/mL; P ¼ .66). When endovascularly treated limbs wereexamined in isolation, multivariate analysis demonstrated that higher hsCRP
levels were signiﬁcantly associated with MALE (hazard ratio [HR], 1.2; 95%
conﬁdence interval [CI] 1.0-1.4; P ¼ .02; Table). In surgical reconstruc-
tions, neither BNP nor hsCRP was associated with MALE; however, the
use of a vein bypass conduit (vs prosthetic reconstruction) signiﬁcantly pred-
icated MALE (HR, 3.5; 95% CI, 1.6-7.6; P < .01). HsCRP failed to asso-
ciated with MACE in endovascularly or surgically treated limbs. However,
elevated BNP levels associated with MACE in the surgical cohort (HR,
1.03; 95% CI, 1.01-1.04; P < .01) but not in those receiving endovascular
intervention.
Conclusions: Elevated hsCRP levels predicted inferior results in
endovascular reconstructions, whereas elevated BNP levels associated with
impaired long-term survival in patients with surgical revascularizations.
Additional studies should use biochemical markers to further stratify out-
comes after both types of vascular interventions as a means to elucidate
how biomarkers can best assist clinical decision-making for outcome
improvement.
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Introduction: An iCAST covered balloon-expandable stent (Maquet
Getinge Group, Hudson, NH) has been used in the superior mesenteric ar-
tery (SMA) to treat a variety of pathology and most recently for visceral
stenting in fenestrated endovascular aortic repair (FEVAR). Stenting has
primarily been investigated by bench studies involving ﬁnite element analysis
in the coronaries; however, further explanation of the mechanical behavior
has not been performed. This study examined Atrium stent expansion using
a pseudoballoon and then a second simulation expanding the stent into a
theoretical SMA.
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(DS Solidworks Corp, Waltham, Mass). A laser-cut tube was fabricated to
strut dimensions and stent length (38 mm) taken from microscopic photo-
graphs. A straight arterial model of 40 mm in length was created using
lumen dimensions from computed tomography scanned data. The stent
was inserted to 40% coverage within the SMA. These models were imported
and meshed in Abaqus 6.13 (Dassault Systemes Simulia Corp, Providence,
RI). Surface-to-surface contact between the stent and the balloon, self-con-
tact, and stent-to-arterial lumen was used between the stent using the
Lagrangian penalty method. Nonlinear hyperelastic material properties
were derived using a ﬁve-parameter strain energy function in Abaqus 6.13.
316L stainless steel stress strain data was used for the stent. The balloon
and SMA was constrained to expand only in the radial direction, uq ¼ uZ
¼ 0. The boundary conditions, uq ¼ uZ ¼ 0, were applied to the stent at
the central midpoints. The stent and stent-in-artery simulation process
occurred in four steps: (1) stent crimping, (2) stent relaxation, (3) stent
expansion, and (4) stent relaxation.
Results: The analysis showed plastic yielding of the struts at the crown
sections causing the stent to “lock” into a ﬁxed position that was deter-
mined by using the von Mises yielding criterion and analyzing the strain
formulation throughout these regions. Elastic recoil does occur in the
model of <5% and foreshortening <5%. The crown regions show a “ﬁsh
scaling” effect. Higher stresses were generated at the regions of stent con-
tact between the stent and the intimal surface. The von Mises stress range
was 6 to 42 kPa, with the outside of the artery showing a stress range of
3 to 6 kPa (Fig). The expanded stent into the arterial vessel shows a mapped
stress distribution <2 MPa along the luminal wall for circumferential, radial,
and axial stresses.
Conclusions: The Atrium stent plastically deforms to a ﬁxed position
with minimal elastic recoil, without arterial interactions. More recoil is expe-
rienced with the addition of the SMA. The use of ﬁnite element analysis has
shown the stent can retain an open position for blood ﬂow while maintain-
ing higher stress distributions localized at the crown regions and edge of the
stent in contact with the lumen of the intimal layer. The impact of these
stresses is the focus of continuing research. The expansion and relaxation
of the stent, with areas of high stress, could lead to an inﬂammatory
response and possible intimal hyperplasia.Fig. The stent was expanded to a 3mm balloon diameter showing (A) the
von Mises Stress distribution with stent plastic yielding shown in red and
higher localized von Mises stresses at the intima and medial layer at stent
crown regions.
Fig 1. Preoperative three-dimesional reconstruction of computerized axial
tomogram showing bilateral renal arteriovenous malformations (AVMs)
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Introduction: We report the successful treatment of a 39-year-old
man presenting with congenital renal arteriovenous malformations
(AVMs). The AVMs were initially suspected from auscultation of a ﬂank
bruit and conﬁrmed by multiple imaging modalities. The clinical pre-
sentation included headaches, hypertension, and reduced exercise
tolerance.
Methods: Imaging revealed bilateral high-ﬂow AVMs in the lower
poles of the kidneys (Fig 1). With arteriography, the normal renal paren-
chyma failed to visualize secondary to the high-ﬂow steal of the AVMs.
The inferior vena cava (IVC) measured 5.5 cm secondary to the increased
volume. The AVM on the right measured 14 cm  11 cm. The AVM on
the left measured 4 cm  4 cm.
Results: The left renal AVM was treated ﬁrst with standard coil
embolization techniques. Renal function scans were obtained at each
stage of the management and remained unchanged. Standard at-
tempts at coil embolization of the larger right cavernous renal
AVM were unsuccessful, with rapid movement of the largest available
constrained embolization devices through the AVM into the IVC.
Successful occlusion of the AVM was accomplished using novel endo-
vascular techniques. Balloon occlusion of the venous outﬂow was
performed via a right internal jugular approach. Two self-expanding
10-mm carotid Wallstents were deployed horizontally into the
AVM and used as a scaffold for additional embolization coils
(Fig 2). Postprocedural ultrasound examination demonstrated suc-
cessful occlusion of the AVMs with normalization of the IVC diam-
eter. At 18 months of follow-up, the patient’s headaches resolved, his
blood pressure was well controlled, and his renal function and exer-
cise tolerance returned to normal. We will discuss the clinical mani-
festations and surgical and endovascular alternatives for management
of renal AVMs.
Conclusions: We report a novel endovascular technique for manage-
ment of bilateral renal AVMs.
